MRNA Trade on Jul 23, 2020 13:00 from beno: Tradervue User Stock Trades.

Fundamentals

N/a

Catalysts / News / Painting the picture

-Corona virus sympathy
-Health officials say virus vaccine development has 'no glitches'
-Feb 11 2020: $500m IPO @ $19 per share
-mRNA-1273 coronavirus vaccine sent for testing
-March 16 2020: First human trial of COVID-19 vaccine
-April 15 2020: PT increase to 41, Making new ATH's
-April 16 2020: Wins $483 Million US Government Award To Develop Coronavirus Vaccine
-May 01 2020: Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Modernas Vaccine (mRNA-1273)
-May 06 2020: Weak earnings / lags estimates, FDA approves phase 2 of COVID-19 vaccine
-Jun 03 2020: MRNA in top 5 pick for vaccine candidate
-Jul 13 2020: MRNA to join NASDAQ 100 Index
-Jul 23 2020: Lost nano particle patent against ABUS, vaccine could be in jeopardy

Technical Analysis

-SPY pattern: Fade
-Intraday pattern: Fade
-Other notes: N/a

Strategy / Confluence / Sizing Guide / Risk

Strategy: FT-15 short of 80 level
Confluence: Whole $, VWAP
Strike Zone: 79.5 - 80
Sizing (lots + emergency): 250
Risk (stop / Rs): 80.51

Review / Lessons Learned

Should have sized up, didn't get big enough for how good setup was. I should really consider holding some of these FT-15 setups for longer... Piked the cover big time